382 related articles for article (PubMed ID: 29870979)
1. Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment.
Ott C; Gerken M; Hirsch D; Fest P; Fichtner-Feigl S; Munker S; Schnoy E; Stroszczynski C; Vogelhuber M; Herr W; Evert M; Reng M; Schlitt HJ; Klinkhammer-Schalke M; Teufel A
Digestion; 2018; 98(3):143-152. PubMed ID: 29870979
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of mucinous histology depends on microsatellite instability status in patients with stage III colon cancer treated with adjuvant FOLFOX chemotherapy: a retrospective cohort study.
Kim SH; Shin SJ; Lee KY; Kim H; Kim TI; Kang DR; Hur H; Min BS; Kim NK; Chung HC; Roh JK; Ahn JB
Ann Surg Oncol; 2013 Oct; 20(11):3407-13. PubMed ID: 23943026
[TBL] [Abstract][Full Text] [Related]
3. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.
Asare EA; Compton CC; Hanna NN; Kosinski LA; Washington MK; Kakar S; Weiser MR; Overman MJ
Cancer; 2016 Jan; 122(2):213-21. PubMed ID: 26506400
[TBL] [Abstract][Full Text] [Related]
4. [Influence of mucinous and signet-ring cell differentiation on epidemiological, histological, molecular biological features, and outcome in patients with colorectal carcinoma].
Benedix F; Kuester D; Meyer F; Lippert H
Zentralbl Chir; 2013 Aug; 138(4):427-33. PubMed ID: 22274919
[TBL] [Abstract][Full Text] [Related]
5. Mucinous rectal cancer: effectiveness of preoperative chemoradiotherapy and prognosis.
Shin US; Yu CS; Kim JH; Kim TW; Lim SB; Yoon SN; Yoon YS; Kim CW; Kim JC
Ann Surg Oncol; 2011 Aug; 18(8):2232-9. PubMed ID: 21347780
[TBL] [Abstract][Full Text] [Related]
6. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.
Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH
Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868
[TBL] [Abstract][Full Text] [Related]
7. [Survival rates of patients with mucinous adenocarcinoma of the colorectum].
Maksimović S
Med Arh; 2007; 61(1):26-9. PubMed ID: 17582971
[TBL] [Abstract][Full Text] [Related]
8. Survival after curative resection for mucinous adenocarcinoma of the colorectum.
Kanemitsu Y; Kato T; Hirai T; Yasui K; Morimoto T; Shimizu Y; Kodera Y; Yamamura Y
Dis Colon Rectum; 2003 Feb; 46(2):160-7. PubMed ID: 12576888
[TBL] [Abstract][Full Text] [Related]
9. The association of mucinous histology with clinicopathological characteristics and long-term oncological outcome in patients with colorectal cancer.
Tümay V; Guner OS
Ann Ital Chir; 2020; 91():639-648. PubMed ID: 32990276
[TBL] [Abstract][Full Text] [Related]
10. The role of adjuvant chemotherapy in stage II and III mucinous colon cancer.
Fields AC; Lu P; Goldberg J; Irani J; Bleday R; Melnitchouk N
J Surg Oncol; 2019 Dec; 120(7):1190-1200. PubMed ID: 31536150
[TBL] [Abstract][Full Text] [Related]
11. Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinoma.
Hugen N; Verhoeven RH; Radema SA; de Hingh IH; Pruijt JF; Nagtegaal ID; Lemmens VE; de Wilt JH
Ann Oncol; 2013 Nov; 24(11):2819-24. PubMed ID: 24057984
[TBL] [Abstract][Full Text] [Related]
12. Mucinous Histology Signifies Poor Oncologic Outcome in Young Patients With Colorectal Cancer.
Soliman BG; Karagkounis G; Church JM; Plesec T; Kalady MF
Dis Colon Rectum; 2018 May; 61(5):547-553. PubMed ID: 29578919
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of mucinous and signet-ring cell colorectal cancer in a population-based cohort.
Nitsche U; Friess H; Agha A; Angele M; Eckel R; Heitland W; Jauch KW; Krenz D; Nüssler NC; Rau HG; Ruppert R; Schubert-Fritschle G; Wilhelm D; Werner J; Engel J
J Cancer Res Clin Oncol; 2016 Nov; 142(11):2357-66. PubMed ID: 27573386
[TBL] [Abstract][Full Text] [Related]
14. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?
Ayhan M; Turan N; Köstek O; Tufan G; Tataroğlu Özyükseler D; Odabas H; Sakin A; Turan M; Sürmeli H; Yıldırım ME
Curr Probl Cancer; 2021 Jun; 45(3):100670. PubMed ID: 33129567
[TBL] [Abstract][Full Text] [Related]
15. Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer.
Negri FV; Wotherspoon A; Cunningham D; Norman AR; Chong G; Ross PJ
Ann Oncol; 2005 Aug; 16(8):1305-10. PubMed ID: 15857840
[TBL] [Abstract][Full Text] [Related]
16. Prognoses of different pathological subtypes of colorectal cancer at different stages: A population-based retrospective cohort study.
Wu X; Lin H; Li S
BMC Gastroenterol; 2019 Oct; 19(1):164. PubMed ID: 31601167
[TBL] [Abstract][Full Text] [Related]
17. Mucinous Adenocarcinomas Histotype Can Also be a High-Risk Factor for Stage II Colorectal Cancer Patients.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai S
Cell Physiol Biochem; 2018; 47(2):630-640. PubMed ID: 29794464
[TBL] [Abstract][Full Text] [Related]
18. Inverse effect of mucinous component on survival in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Yamamoto G; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(7):851-7. PubMed ID: 25111953
[TBL] [Abstract][Full Text] [Related]
19. Association of pathway mutation with survival after recurrence in colorectal cancer patients treated with adjuvant fluoropyrimidine and oxaliplatin chemotherapy.
Lee DW; Han SW; Cha Y; Bae JM; Kim HP; Lyu J; Han H; Kim H; Jang H; Bang D; Won JK; Jeong SY; Park KJ; Kang GH; Kim TY
BMC Cancer; 2019 May; 19(1):421. PubMed ID: 31060539
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.
Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP
J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
